Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation: A critical period of time is required for development of immunological unresponsiveness

Transplantation

Volumn 61, Issue 11, 1996, Pages 1642-1647

  Saitovitch, David ^a   Bushell, Andrew ^a   Mabbs, Duncan W ^a   Morris, Peter J ^a   Wood, Kathryn J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DONOR; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSFUSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BLOOD TRANSFUSION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029893961     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199606150-00016     Document Type: Article

References (29)

1. Loveland BE, Hogarth PM, Ceredig R, Mckenzie IFC. Cells mediating graft rejection in the mouse: I. Lyt-1 cells mediate skin graft rejection. J Exp Med 1981; 153: 1044.
2. Dallman MJ, Mason DW. Role of thymus-derived and thymus-independent cells in murine skin allograft rejection. Transplantation 1982; 33: 221.
3. Cobbold SP, Jayasuria A, Nash A, Prospero TD, Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984; 312: 548.
4. Brostoff SW, Mason DW. Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J Immunol 1984; 133: 1938.
5. Wofsy D, Seaman WE. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 1985; 161: 379.
6. Wofsy D, Seaman WE. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J Immunol 1987; 138: 3247.
7. Madsen JC, Peugh WN, Wood KJ, Morris PJ. The effect of anti-L3T4 monoclonal antibody on first-set rejection of murine cardiac allografts. Transplantation 1987; 44: 849.
8. Qin S, Cobbold S, Tighe H, Benjamin R, Waldmann H. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur J Immunol 1987; 17: 1159.
9. Shizuru JA, Gregory AK, Chao CTB, Fathman CG. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 1987; 237: 278.
10. Lindsey JW, Hodgkinson S, Mehta R, et al. Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis. Neurology 1994; 44: 413.
11. Ahlberg R, Yi Q, Pirskanen R, et al. Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivity. Neurology 1994; 44: 1732.
12. Jonker M, Slingerland W, Treacy G, et al. In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees. Clin Exp Immunol 1993; 93: 301.
13. Pearson TC, Madsen JC, Larsen CP, Morris PJ, Wood KJ. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation 1992; 54: 475.
14. Pearson TC, Bushell AR, Darby CR, West LJ, Morris PJ, Wood KJ. Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody. Clin Exp Immunol 1993; 92: 211.
15. Cobbold SP, Martin G, Waldmann H. The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies. Eur J Immunol 1990; 20: 2747.
16. + T cells. Transplantation 1992; 54: 483.
17. Qin S, Wise M, Cobbold SP, et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990; 20: 2737.
18. Corry R, Winn H, Russell P. Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K and non- H-2 antigens in rejection. Transplantation 1973; 16: 343.
19. Superina RA, Peugh WN, Wood KJ, Morris PJ. Assessment of primarily vascularized cardiac allografts in mice. Transplantation 1986; 42: 226.
20. Peto R, Pike P, Armitage P, et al. Design and analysis of randomized clinical trials which require prolonged observations of each patient: II. analysis and examples. Br J Cancer 1977; 35: 1.
21. Darby CR, Bushell AR, Morris PJ, Wood KJ. Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade. Transplantation 1994; 57: 1419.
22. Bushell AR. Transplantation tolerance in the mouse induced by antigen and anti-CD4 antibody: mechanisms and strategies. DPhil Thesis, University of Oxford, 1993.
23. + T cell regulation during the induction phase of the response. Eur J Immunol 1995; 25: 2643.
24. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993; 259: 975.
25. + T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med 1995; 182: 5.
26. Siegling A, Lehmann M, Riedel H, et al. A nondepleting anti-rat CD4 monoclonal antibody that suppresses T helper 1-like but not T helper 2-like intragraft lymphokine secretion induces long-term survival of renal allografts. Transplantation 1994; 57: 464.
27. Scully R, Qin S, Cobbold S, Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994; 24: 2383.
28. Van Twyver E, Mooijaart RJD, Ten Berge IJM, et al. Pretransplantation blood transfusion revisited. N Engl J Med 1991; 325: 1210.
29. Lehmann M, Havlickova J, Risch K, et al. Role of the spleen in the establishment and maintenance of anti-CD4-induced transplant nonresponsiveness. Transplant Proc 1995; 27: 121.